These FDA-approved peptides are medications with robust safety data and proven efficacy
Similar to all GLP-1 RA medications and due to the mechanism of the drug, Rybelsus reduces gut motility (this is usually what make people feel fuller faster), and mild to moderate stomach upset and/or nausea may occur
Abdelnour SA, Sindi RA, Abd El-Hack ME, Khalifa NE, Khafaga AF, Noreldin AE, Samir H, Tufarelli V, Losacco C, Gamal M, Imam MS, Swelum AA
In clinical studies, significant weight loss was observed around the 24-week mark, with continued progress through 48 weeks
These effects are typically dose-dependent and often diminish over time with continued use